Opportunity Radar

← Back to search

Grant

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
G
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
RFA-DA-26-034
Posted
Nov 20, 2024
Response due
Nov 18, 2027
Archive date
Dec 24, 2027
CFDA / Assistance listing
93.233,93.279,93.837,93.838,93.839,93.840,93.855
Award ceiling
$300,000
Total program funding
$300,000
Contact
grantsinfo@nih.gov
Source
Grants.gov

Description

This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.

Similar open opportunities